MSLE
Satellos Bioscience Inc. Common Stock
NASDAQ · Healthcare · Medical - Pharmaceuticals · CA
$8.97
−1.21%Institutional positioning
13F filings over the trailing two quarters
New 31Increased 1Reduced 0Sold out 30
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FRANKLIN RESOURCES INC | New Position | 938,666 | May 13, 2026 |
| SIREN, L.L.C. | New Position | 892,074 | May 14, 2026 |
| VIVO CAPITAL, LLC | New Position | 813,666 | May 20, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | New Position | 690,778 | May 15, 2026 |
| WOODLINE PARTNERS LP | New Position | 500,432 | May 15, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | New Position | 489,207 | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | New Position | 475,000 | May 15, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | New Position | 414,359 | May 14, 2026 |
| AVIDITY PARTNERS MANAGEMENT LP | New Position | 387,769 | May 28, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New Position | 380,354 | May 15, 2026 |
| SATURN V CAPITAL MANAGEMENT LLC | New Position | 350,000 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | New Position | 298,433 | May 15, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | New Position | 230,833 | May 15, 2026 |
| EMPERY ASSET MANAGEMENT, LP | New Position | 230,100 | May 8, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | New Position | 222,555 | May 18, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings